by Jordana Choucair | Apr 20, 2022 | Opioid/Substance Use Disorders
Alabama reached a $276 million settlement with Johnson & Johnson, McKesson Corp., and Endo International PLC to resolve claims that they fueled the opioid crisis. The state attorney general said the money will go toward the state’s efforts to combat...
by Jordana Choucair | Apr 19, 2022 | Opioid/Substance Use Disorders
West Virginia announced it finalized a settlement with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. over the drugmaker’s role in perpetuating the state’s opioid crisis. According to Attorney General Patrick Morrisey, the $99 million settlement is...
by Jordana Choucair | Apr 14, 2022 | Opioid/Substance Use Disorders
The Alliance for Addiction Payment Reform released a new brief that explores how utilizing coordinated and comprehensive medication management (CMM) in substance use disorder (SUD) treatment and recovery can enhance access to high quality care. CMM services for SUD...
by Jordana Choucair | Apr 14, 2022 | Opioid/Substance Use Disorders
A new congressional report found that more than 20 employees from consulting firm McKinsey worked for the U.S. government on issues related to the opioid epidemic while also doing the same type of consulting for major opioid makers like Purdue Pharma. The report...
by Jordana Choucair | Apr 13, 2022 | Opioid/Substance Use Disorders
Eleanor Health, an addiction and mental health care provider, has secured $50 million in a series C funding round led by General Catalyst. The startup’s evidence-based care model offers a variety of addiction and mental health services with a tech platform that allows...
by Jordana Choucair | Apr 12, 2022 | Opioid/Substance Use Disorders
Forge Health, a company that provides both in-person and digital mental health and substance use treatment, secured $11 million in new financing to build out its tech capabilities and expand its value-based partnerships. The company plans to use the funding to expand...
Recent Comments